Pharmaceutical Data
Drug adverse events, recalls, approvals, shortages, and spending
Data Listings
Pharmaceuticals: Regulators, Approved-Drug Databases & Safety Registries
A free, platform-curated directory of the regulators, approved-drug databases, and safety registries that govern U.S. and international pharmaceuticals, sourced from official sites. Each record gives the entity's name, role, jurisdiction, and official URL. Designed for regulatory, safety, and research teams who need one trustworthy map of where approvals, labeling, adverse events, and shortages are published.
Pharmaceuticals: Drug Codes, Identifiers & Regulatory-Terms Glossary
A free, platform-curated glossary of the drug codes, identifiers, and regulatory terms used across pharmaceutical development and safety, with precise plain-language definitions consistent with FDA, DEA, WHO, and NLM usage. Each record gives the term, its definition, a category, and a reference note. Ideal for onboarding, agent grounding, and buyers who need a shared, citable vocabulary for drug coding and regulation.
Pharmaceuticals: FDA Approval Pathways, Review Timelines & Recall Classes
A free, platform-curated reference to the FDA drug approval pathways, review-timeline goals, expedited programs, and recall classes, compiled from FDA guidance and statute. Each record gives the item, its category, a definition, the statutory or reference basis, and the source. Built for regulatory, pharmacovigilance, and market-access teams who need dependable public-domain facts on how U.S. drugs are approved and recalled.
Reference Listing: Pharmaceutical Data — Adverse Events, Shortages & Approval Intelligence
ReferenceOfficial reference for the Pharmaceuticals vertical. Buyers are market-access analysts, supply-chain planners, and safety monitors. Public regulatory data is free but messy; the paid layer is cleaning, joining, and forward signal: deduplicated adverse-event panels with denominator estimates (events per prescription volume, not raw counts), shortage early-warning datasets built from purchasing and filing signals, approval-timeline models with historical accuracy stated, and list-vs-net price estimates with methodology — the example rows show it. Critical platform rule: personal health and medical records are prohibited — this vertical is drug-level and market-level data only, never patient-level. Denominator work is what buyers pay for; raw event counts without exposure context are free elsewhere and worthless. Cite public sources per row. Listing is free, sellers keep 95% on everyday sales from $20 to $49,999.99 under the year-one founding rate locked through 2027-06-30 (full schedule: GET /api/meta), and datasets are relayed live from your verified endpoint — never stored by the platform. Purchase this free reference to walk the buy-deliver-receipt sequence before transacting on real listings.
API Integration
curl -X GET "https://verticalmarketplace.ai/api/marketplace/listings?vertical=pharma"
# Pay-per-query an open-license listing in USDC (no account)
curl -X GET "https://verticalmarketplace.ai/api/x402/listings/LISTING_ID/query"